Search results

• 2025

  Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK

  Cleare, A., Kerr Gaffney, J., Goldsmith, K., Zenasni, Z., Yaziji, N., Jin, H., Colasanti, A., Geddes, J., McAllister-Williams, R. H., Young, A., Barrera, A., Marwood, L., Taylor, R. & Tee, H., 19 Mar 2025, In: The Lancet Psychiatry. 12, 4, p. 276-288 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Cost-Effectiveness Analysis 100%
  • Quetiapine 100%
  • Treatment Resistant Depression 100%
  • Treatment-Resistant Depression 100%
  • Health Care Cost 33%
  2 Citations (Scopus)

  43 Downloads (Pure)

• Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial

  Kerr-Gaffney, J., Zenasni, Z., Goldsmith, K., Yaziji, N., Jin, H., Colasanti, A., Geddes, J., Kessler, D., McAllister-Williams, R. H., Young, A. H., Barrera, A., Marwood, L., Taylor, R. W., Tee, H., Cleare, A. J., Rucker, J., Williams, R., Day, C., Bountouni, I. & Juruena, M. & 68 others, Jelen, L., Edwards, A., Kan, C., Jairaj, C., Waterman, L., McCutcheon, R., Gadelrab, R., Patel, R., McLoughlin, P., Day, E., Shah, R., Cattell, J., de Angel, V., Incecik, E., Ancane, A., Oprea, E., Ulrichsen, A., Nikolova, V., Mantingh, T., Tsapekos, D., Pickles, A., Dietch, D., Strawbridge, R., Romeo, R., Holland, R., Watson, S., Marey, H., Ahuja, N., Arebi, E., Armstrong, D., Buruju, D., Emechebe, A., Esi, O., Healicon, J., Osman, S., Stageman, W., Sud, N., Raj, V., Burgess, J., Hutchinson, J., Nortey, K., Wilson, S., Hall, W., Swift, J., Carr, R., Hamilton, J., Reilly, J., Nair, R., Cowen, P., Browning, M., McKeown, L., Mather, S., Potts, J., Millar, C., Hollingsworth, S., Dean, R., Morgan, C., Harvey, J., Davies, F., Cipriani, A., Attenburrow, M. J., Evans, J., Davies, J., Leach, R., de S’a, C. R., Pooley, J., Emery, G. & Gregory, S., 8 May 2025, In: Health Technology Assessment. 29, 12

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Randomized Controlled Trial 100%
  • Cost-Effectiveness Analysis 100%
  • Quetiapine 100%
  • Treatment Resistant Depression 100%
  • Cost Effectiveness Analysis 100%
  3 Downloads (Pure)
• 2023

  Peripheral inflammatory effects of different interventions for treatment-resistant depression: A systematic review

  Strawbridge, R., Izurieta, E., Day, E., Tee, H., Young, K., Tong, C. C., Young, A. H. & Cleare, A. J., Jan 2023, In: Neuroscience Applied. 2, 101014.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Systematic Review 100%
  • Ketamine 100%
  • Treatment Resistant Depression 100%
  • Treatment-Resistant Depression 100%
  • Electroconvulsive Therapy 80%
  6 Citations (Scopus)
• 2022

  Patient perspectives of lithium and quetiapine augmentation treatment in treatment resistant depression: A qualitative assessment

  McKeown, L., Taylor, R., Day, E., Shah, R., Marwood, L., Tee, H., Kerr Gaffney, J., Oprea, E., Geddes, J., McAllister-Williams, R. H., Young, A. & Cleare, A., 27 Apr 2022, (E-pub ahead of print) In: Journal of Psychopharmacology.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  8 Citations (Scopus)

• Peripheral inflammatory effects of different interventions for treatment-resistant depression: A systematic review

  Strawbridge, B., Day, E., Tee, H., Tong, C., Young, A. & Cleare, A., 1 Nov 2022, In: Neuroscience Applied. 101014.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Systematic Review 100%
  • Ketamine 100%
  • Treatment Resistant Depression 100%
  • Treatment-Resistant Depression 100%
  • Electroconvulsive Therapy 80%